Moreover, compared to the non-cancerous tissue, there is a 24% increase in MST4 gene expression for the luminal sub-type, a 52% increase in the HER2 type, and a 144% increase in triple negative breast cancer TNBC (Figure 6b). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.